Xcout Intel
Cypre Inc.
Cypre Inc. is a biotechnology company headquartered in San Francisco, California, that develops 3D tumor models and oncology platforms for drug discovery.
Subscribe to see Cypre Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cypre Inc. at a glance
Cypre Inc. is a biotechnology company headquartered in United States. It has raised at least $22.2M across the 3 funding rounds on record. Its most recent funding round raised $1.7M in December 2023. Xcout tracks 3 named people at Cypre Inc., including Kolin C. Hribar (CEO & Founder).
Cypre Inc. leadership
- Kolin C. HribarCEO & Founder
- Ellen ChangBoard Member
- Kyle DerhamBoard Member
Cypre Inc. funding rounds
At least $22.2M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.7M | — | |
| Series A | $19M | — | |
| SEC Form D filing | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Cypre Inc. competitors
A few of Cypre Inc.'s closest competitors — see the full list of competitors and alternatives →
Vivodyne is a biotechnology company headquartered in Philadelphia, Pennsylvania, with presence in the San Francisco Bay Area, that uses autonomous labs to grow realistic human tissues and generate human data at scale for pharmaceutical research.
Standard Model Biomedicine is a biotechnology research company based in San Francisco, United States. The company is focused on developing a foundation model for human biology to advance biomedical research.
CytoReason provides a computational disease modeling platform designed for pharmaceutical R&D. The company's technology uses human data to help scientists and executives map disease mechanisms, prioritize drug portfolios, and predict treatment performance.
Convexia is a biotechnology research company headquartered in San Francisco, California, United States. It utilizes an end-to-end AI stack to quickly find and acquire early-stage drugs, replacing traditional manual diligence processes with fast execution.
Sculpta Bio is a biotechnology research company headquartered in San Francisco, California, known as the Protein Sculpting Company.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Get Cypre Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Cypre Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cypre Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access